Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATP4A | P20648 | 15/20 | 0.63 |
| ▸ | ATP4B | P51164 | 15/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.63 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.63 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.63 |
| ▸ | FASN | P49327 | 1/20 | 0.63 |
| ▸ | SLC47A2 | Q86VL8 | 1/20 | 0.63 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.63 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.63 |
| ▸ | ATP1A1 | P05023 | 9/20 | 0.54 |
| ▸ | ATP1B1 | P05026 | 9/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pantoprazole SCHEMBL29463615 | 1.00 | ATP4A (0.63) | ATP4AATP4BCYP2C9CYP3A4KDM4E | |
| Pantoprazole SCHEMBL22198 | 1.00 | ATP4A (0.63) | ATP4AATP4BCYP2C9CYP3A4KDM4E | |
| Pantoprazole SCHEMBL29530572 | 1.00 | ATP4A (0.63) | ATP4AATP4BCYP2C9CYP3A4KDM4E | |
| Pantoprazole SCHEMBL723548 | 1.00 | ATP4A (0.63) | ATP4AATP4BCYP2C9CYP3A4KDM4E | |
| Pantoprazole SCHEMBL30777582 | 1.00 | ATP4A (0.63) | ATP4AATP4BCYP2C9CYP3A4KDM4E | |
| Pantoprazole SCHEMBL3179782 | 0.99 | ATP4A (0.62) | ATP4AATP4BCYP2C9CYP3A4KDM4E | |
| Pantoprazole SCHEMBL289961 | 0.99 | ATP4A (0.62) | ATP4AATP4BCYP2C9CYP3A4KDM4E | |
| Pantoprazole SCHEMBL1994486 | 0.99 | ATP4A (0.62) | ATP4AATP4BCYP2C9CYP3A4KDM4E | |
| Pantoprazole SCHEMBL1716779 | 0.99 | ATP4A (0.62) | ATP4AATP4BCYP2C9CYP3A4KDM4E | |
| Pantoprazole SCHEMBL29001005 | 0.99 | ATP4A (0.62) | ATP4AATP4BCYP2C9CYP3A4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 17825 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107208-A1 | COMPOSITIONS AND METHODS FOR TREATING MICROBIAL INFECTIONS | THE METHODIST HOSPITAL (US) | 2026-05-21 | — | — | WO | claimed |
| CN-122038311-A | Phage for broad-spectrum splitting of drug-resistant Klebsiella pneumoniae, phage composition and application thereof | 济南市中心医院 | 2026-05-15 | — | — | CN | claimed |
| CN-122036684-A | Preparation method of levorotatory pantoprazole sodium double-hemi-hydrate | 杭州中美华东制药有限公司 | 2026-05-15 | — | — | CN | claimed |
| EP-4735895-A1 | HELICOBACTER CAGA PEPTIDES AND THEIR USE IN DIAGNOSIS | Biotome Pty Ltd (AU) | 2026-05-06 | — | — | EP | claimed |
| WO-2026090593-A2 | RNA BIOMARKERS FOR USE IN BARRETT'S ESOPHAGUS | CITY OF HOPE (US) | 2026-04-30 | — | — | WO | claimed |
| US-20260115161-A1 | 2-HYDROXY-OCTADECENE-9-CIS-OATE FOR USE IN THE TREATMENT OF ONCOLOGICAL PATHOLOGIES AND NEUROPATHIC PAIN | LAMINAR PHARMACEUTICALS S A (ES) | 2026-04-30 | — | — | US | claimed |
| EP-4731180-A1 | A POWDER COMPOSITION FOR ORAL SUSPENSION OF PROTON PUMP INHIBITORS AND THE METHOD OF PREPARING THE SAME | Orbit Pharma Limited (GB) | 2026-04-29 | — | — | EP | claimed |
| EP-3790536-B1 | NANOCONTAINERS FOR TRANSPORTING NONPOLAR, LIPOPHILIC SUBSTANCES SUCH AS ANTIBIOTICS | KARLSRUHER INST TECHNOLOGIE (DE) | 2026-04-22 | — | — | EP | claimed |
| US-20260097026-A1 | INHIBITION OF AORTIC VALVE CALCIFICATION | ZABIRNYK ARSENII (NO) | 2026-04-09 | — | — | US | claimed |
| US-20260091116-A1 | COMPOSITIONS AND KITS FOR OMEPRAZOLE SUSPENSION | AZURITY PHARMACEUTICALS, INC. | 2026-04-02 | — | — | US | claimed |
| EP-0696921-A1 | VETERINARY COMPOSITION CONTAINING A PROTON PUMP INHIBITOR | Astra Aktiebolag (SE) | 1996-02-21 | — | — | EP | claimed |
| EP-0695123-A1 | METHODS AND COMPOSITIONS FOR TREATING GASTRIC DISORDERS USING OPTICALLY PURE (-) PANTOPRAZOLE | SEPRACOR, INC. (US) | 1996-02-07 | — | — | EP | claimed |
| WO-1996002236-A1 | IMPROVED COMBINATION DOSE UNIT | MOORE TREVOR (AU) | 1996-02-01 | — | — | WO | claimed |
| WO-1995018612-A1 | A METHOD FOR TREATMENT OF PSORIASIS, BY OMEPRAZOLE OR RELATED COMPOUNDS | AKTIEBOLAGET ASTRA (SE) | 1995-07-13 | — | — | WO | claimed |
| WO-1995000478-A1 | ARYLTRIFLATES AND RELATED COMPOUNDS | LUNDBECK & CO AS H (DK) | 1995-01-05 | — | — | WO | claimed |
| WO-1995000527-A1 | FUCOSYLATED GLYCOSIDES AS INHIBITORS OF BACTERIAL ADHERENCE | ASTRA AKTIEBOLAG (SE) | 1995-01-05 | — | — | WO | claimed |
| WO-1994025028-A1 | METHODS AND COMPOSITIONS FOR TREATING GASTRIC DISORDERS USING OPTICALLY PURE (+) PANTOPRAZOLE | SEPRACOR, INC. (US) | 1994-11-10 | — | — | WO | claimed |
| WO-1994024867-A1 | METHODS AND COMPOSITIONS FOR TREATING GASTRIC DISORDERS USING OPTICALLY PURE (-) PANTOPRAZOLE | SEPRACOR, INC. (US) | 1994-11-10 | — | — | WO | claimed |
| WO-1994025070-A1 | VETERINARY COMPOSITION CONTAINING A PROTON PUMP INHIBITOR | ASTRA AKTIEBOLAG (SE) | 1994-11-10 | — | — | WO | claimed |
| CN-1067809-A | Oral dosage forms of acid-labile active compounds | BYK GULDEN LOMBERG CHEM FAB (DE) | 1993-01-13 | — | — | CN | claimed |